NATIONAL BANK OF CANADA /FI/ - PROTALIX BIOTHERAPEUTICS INC ownership

PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A309. A total of 28 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.0%.

Quarter-by-quarter ownership
NATIONAL BANK OF CANADA /FI/ ownership history of PROTALIX BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$53,099
-90.5%
34,000
-88.8%
0.00%
-100.0%
Q2 2023$559,785
+4290.8%
303,800
+4880.3%
0.00%
Q1 2023$12,749
+52.6%
6,1000.0%0.00%
Q4 2022$8,357
+39.3%
6,1000.0%0.00%
Q3 2022$6,000
-14.3%
6,1000.0%0.00%
Q2 2022$7,000
+16.7%
6,1000.0%0.00%
Q1 2022$6,000
+20.0%
6,100
+1.7%
0.00%
Q4 2021$5,0006,0000.00%
Other shareholders
PROTALIX BIOTHERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Spire Wealth Management 148,800$158,0000.00%
MEITAV INVESTMENT HOUSE LTD 244,332$257,0000.00%
Phoenix Holdings Ltd. 244,113$259,0000.00%
IHT Wealth Management, LLC 24,000$25,0000.00%
Psagot Value Holdings Ltd. / (Israel) 6,000$6,0000.00%
Virtu Financial LLC 15,199$16,0000.00%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 41,574$44,0000.00%
Smith Salley Wealth Management 12,048$13,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 28,790$31,0000.00%
BANK OF AMERICA CORP /DE/ 5,153$5,0000.00%
View complete list of PROTALIX BIOTHERAPEUTICS INC shareholders